Coronary artery disease in women: Different, often undertreated

Hani Jneid, MD
Department of Internal Medicine, Cleveland Clinic

Holly L. Thacker, MD, FACP
Head, Section of Women’s Health, Departments of General Internal Medicine and Obstetrics and Gynecology, Cleveland Clinic; Director of Women’s Health Track GIM Fellowship, Clinical Associate Professor of Medicine, Penn State University

Address: Holly L. Thacker, MD, FACP, Department of General Internal Medicine and Obstetrics and Gynecology, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195;
thackeh@ccf.org

This paper discusses treatment information that is “off-label,” ie, not approved by the Food and Drug Administration for the indication under discussion.

Hani Jneid, MD
Department of Internal Medicine, Cleveland Clinic

Holly L. Thacker, MD, FACP
Head, Section of Women’s Health, Departments of General Internal Medicine and Obstetrics and Gynecology, Cleveland Clinic; Director of Women’s Health Track GIM Fellowship, Clinical Associate Professor of Medicine, Penn State University

Address: Holly L. Thacker, MD, FACP, Department of General Internal Medicine and Obstetrics and Gynecology, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195;
thackeh@ccf.org

This paper discusses treatment information that is “off-label,” ie, not approved by the Food and Drug Administration for the indication under discussion.

Hani Jneid, MD
Department of Internal Medicine, Cleveland Clinic

Holly L. Thacker, MD, FACP
Head, Section of Women’s Health, Departments of General Internal Medicine and Obstetrics and Gynecology, Cleveland Clinic; Director of Women’s Health Track GIM Fellowship, Clinical Associate Professor of Medicine, Penn State University

Address: Holly L. Thacker, MD, FACP, Department of General Internal Medicine and Obstetrics and Gynecology, A91, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195;
thackeh@ccf.org

This paper discusses treatment information that is “off-label,” ie, not approved by the Food and Drug Administration for the indication under discussion.